FIELD: medicine.SUBSTANCE: group of inventions refers to medicine and is intended for diagnosing and treating irritable bowel syndrome (IBS). Described are methods, assays and systems of diagnosing, selecting therapy and treating IBS based on a subject's level of anti-vinculin and anti-CdtB antibodies. IBS is diagnosed if the level of anti-vinculin antibodies exceeds the level of anti-CdtB antibodies.EFFECT: group of inventions enables detecting IBS and differential diagnosis of inflammatory intestinal diseases.21 cl, 2 dwg, 2 tbl, 2 ex
DIAGNOSIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE